$33.21
0.070.21%
At close: -
$33.21
0.000.00%
After Hours: Dec 20, 4:06 PM EDT
Comments
Loading...
Latest news for Apellis Pharmaceuticals (NASDAQ:APLS) Stock
Apellis Pharmaceuticals Stock (NASDAQ: APLS)
Categories: All
Tuesday, December 17, 2024
- Apellis Pharmaceuticals shares are trading lo...
- Mama's Creations Posts Weak Earnings, Joins EVgo, Red Cat Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
- Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (20 Ratings)
- Goldman Sachs Downgrades Apellis Pharmaceutic...
Thursday, November 21, 2024
Tuesday, November 19, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
- Citigroup Maintains Buy on Apellis Pharmaceut...
- Goldman Sachs Maintains Buy on Apellis Pharma...
- RBC Capital Maintains Sector Perform on Apell...
- Scotiabank Maintains Sector Perform on Apelli...
- Wells Fargo Maintains Equal-Weight on Apellis...
- Oppenheimer Maintains Outperform on Apellis P...
- Piper Sandler Maintains Neutral on Apellis Ph...
- Lululemon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
- HC Wainwright & Co. Maintains Buy on Apellis ...
- B of A Securities Maintains Buy on Apellis Ph...
- Needham Maintains Buy on Apellis Pharmaceutic...
Tuesday, November 05, 2024
- Apellis Pharmaceuticals shares are trading lo...
- Celanese Posts Downbeat Results, Joins Cirrus Logic, Teradata And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
- Apellis Pharmaceuticals Reports Cash And Cash...
- Apellis Pharmaceuticals Q3 2024 GAAP EPS $(0....
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Monday, November 04, 2024
Monday, October 28, 2024
Thursday, October 24, 2024
Wednesday, October 16, 2024
- Navigating 18 Analyst Ratings For Apellis Pharmaceuticals
- Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
- Scotiabank Initiates Coverage On Apellis Phar...
- William Blair Initiates Coverage On Apellis P...
- Apellis Announces Oral Presentation On Phase ...